Millipore Sigma will add temporary tariff surcharges on products shipped to the U.S.

What's new in pharma

May 2, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | MilliporeSigma will add temporary tariff surcharges on products shipped to the U.S. Millipore executives explained that the tariffs are "impacting our operations," which include production and procurement costs. By Ed Silverman STAT+ | NIH halts funding for new projects with foreign collaborators, citing national security concerns NIH abruptly halts some foreign research funding, derailing a vital flu vaccine trial and disrupting global health projects By Megan Molteni STAT+ | Another Cytokinetics own goal leaves investors fuming Investors are frustrated by a series of recent blunders by Cytokinetics and its management team, led by CEO Robert Blum. By Adam Feuerstein Andrew Harnik/AP STAT+ | Justice Department sues Medicare Advantage insurers and brokers, alleging kickbacks The lawsuit, filed by the Justice Department, targets CVS Health's Aetna, Elevance Health's Anthem, and Humana, plus three dominant insurance brokerages. By Bob Herman and Tara Bannow

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser